Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Researchers Identify New Source of Powerful Immunity Protein

Published: Thursday, July 11, 2013
Last Updated: Thursday, July 11, 2013
Bookmark and Share
New cellular source for IFN-? that keeps viruses from replicating and stimulates the immune system.

Researchers at UT Southwestern Medical Center report the identification of a new cellular source for an important disease-fighting protein used in the body’s earliest response to infection.

The protein interferon-gamma (IFN-γ) keeps viruses from replicating and stimulates the immune system to produce other disease-fighting agents.

Neutrophils, the newly identified cellular source of the protein, are the major component of the pus that forms around injured tissue.

The researchers also report that the neutrophils appear to produce IFN-γ through a new cellular pathway independent of Toll-like receptors (TLRs): the body’s early warning system for invasion by pathogens.

This finding indicates that mammals might possess a second early-alert system - the sort of built-in redundancy engineers would envy, said Dr. Felix Yarovinsky, assistant professor of immunology and senior author of the study published online in the Proceedings of the National Academy of Sciences in June.

“We believe our mouse study provides strong evidence that neutrophils, white blood cells created in the bone marrow, produce significant amounts of IFN-γ in response to disease,” Dr. Yarovinsky said. “The finding of a new and essential cellular source for IFN-γ challenges a long-held belief in the field and is significant because neutrophils are the most common kind of white blood cell.”

Two pathogens were used in this study: the parasite Toxoplasma gondii - which can cause brain damage in humans and other mammals that have compromised immune systems - and a type of bacterium that causes gastroenteritis, Salmonella typhimurium.

Innate immunity is the body’s first line of defense against pathogens, including those that it has never before encountered.

Adaptive immunity is the secondary system that battles pathogens to which the body has previously been exposed and to which it has developed antibodies.

Textbooks list natural killer (NK) cells and T cells as the body’s significant sources of IFN-γ. Although large numbers of neutrophils have long been observed to congregate at the site of a new infection, they were commonly thought to be first responders or foot soldiers rather than generals in the battle against disease, as this study indicates they are, Dr. Yarovinsky explained.

About 20 years ago, there were clinical reports in humans and animals suggesting that neutrophils might produce IFN-γ, but the idea was largely ignored by the scientific community until the last decade, he said.

Since then, studies at UT Southwestern and elsewhere have found that mice lacking NK and T cells, and therefore expected to be unable to produce IFN-γ, somehow continued to withstand infections better than mice genetically unable to make any IFN-γ.

These observations suggested the possibility of an unknown source of the protein, he explained.

In a series of experiments, the UT Southwestern researchers identified neutrophils as the major source of IFN-γ in mice lacking NK and T cells. “Based on what we know about neutrophils, their large numbers and rapid deployment to the site of infection should provide an important means of very early, robust, and rapid elimination of disease-causing agents,” the researchers wrote. Although neutrophil-derived IFN-γ alone is insufficient to achieve complete host protection, the protein significantly extended the survival of mice in this study, Dr. Yarovinsky said.

In related news, the Burroughs Wellcome Fund in June announced that Dr. Yarovinsky had been selected for its 2013 Investigators in the Pathogenesis of Infectious Disease Award to further investigate mechanisms of host defense against various infectious diseases mediated by IFN-γ produced by neutrophils.

The award will provide $500,000 over five years to pursue this line of research.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
Thursday, January 28, 2016
Enzyme Involved in Cell Division Also Plays a Role in Inflammation
NEK7 enzyme’s switch-like activity in immunity lead to new treatments for a variety of medical conditions linked to inflammation.
Thursday, December 10, 2015
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Tuesday, December 01, 2015
Researchers Identify an Enzyme as a Major Culprit of Autoimmune Diseases
Inhibition of cGAS may be an effective therapy for autoimmune diseases.
Wednesday, October 28, 2015
Boosting Gut Bacteria Defense System May Lead to Better Treatments
Life-threatening bloodstream infections reversed by enhancing a specific immune defense response.
Tuesday, June 09, 2015
Immunity Enzyme Defends Against Tuberculosis Infection
Study shows that cGAS enzyme is essential for defense against the tuberculosis bacteria.
Wednesday, June 03, 2015
Researchers Find New Mechanism That Controls Immune Responses
The findings appear online in the journal Science.
Friday, February 13, 2015
New And Beneficial Function Of Endogenous Retroviruses In Immune Response Identified
ERV play a critical role in the body’s immune defense against common bacterial and viral pathogens.
Friday, December 19, 2014
Scientists Identify New and Beneficial Function of Endogenous Retroviruses
Researchers found that ERV play a critical role in the body’s immune defense against common bacterial and viral pathogens.
Friday, December 19, 2014
UT Southwestern Researcher Selected for ASBMB Merck Award
Award recognizes Dr. Zhijian Chen’s outstanding contributions to research in biochemistry and molecular biology.
Friday, July 18, 2014
Cellular Force That Drives Allergy and Asthma Can be Blocked by Interferon
Type I interferons block the development of allergy- and asthma-driving Th2 cells.
Friday, June 20, 2014
Study Identifies Potential New Strategy to Improve Odds of Corneal Transplant Acceptance
Study findings were reported in the December issue of the American Journal of Transplantation.
Tuesday, December 31, 2013
Identifying How Body Clock Affects Inflammation
UT Southwestern Medical Center researchers report that disrupting the light-dark cycle of mice increased their susceptibility to inflammatory disease.
Friday, November 08, 2013
Promising New Approach to Drug-Resistant Infections
A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings.
Wednesday, October 16, 2013
Dr. Bruce Beutler Elected to American Academy of Arts and Sciences
AAAS has elected Nobel Laureate Dr. Beutler of UT Southwestern Medical Center to membership.
Friday, April 26, 2013
Scientific News
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Neural Networks Adapt to the Presence of a Toxic HIV Protein
HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.
HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
Breaking the Brain’s Garbage Disposal
The children’s ataxia gene problem turned out to be not such a big deal genetically — it was such a slight mutation that it barely changed the way the cells made the protein.
Flesh-Eating Bacteria Work Together
Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!